09:38 AM EDT, 07/23/2024 (MT Newswires) -- BridgeBio Pharma ( BBIO ) Tuesday morning said it has appointed Thomas Trimarchi to the newly created position of chief operating officer at the biopharmaceuticals company.

Trimarchi, who joined BridgeBio in 2018, most recently served as chief product officer.

BridgeBio shares were slipping 1.8% soon after Tuesday's opening bell.

Price: 26.20, Change: -0.47, Percent Change: -1.76